Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates

Journal of Virology

Volumn 82, Issue 11, 2008, Pages 5255-5268

  Maximova, Olga A ^a,d   Ward, Jerrold M ^b   Asher, David M ^a   St Claire, Marisa ^b,c   Finneyfrock, Brad W ^c   Speicher, James M ^b   Murphy, Brian R ^b   Pletnev, Alexander G ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BIOQUAL INC   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE; YELLOW FEVER VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBELLUM; CHIMERA; CONTROLLED STUDY; FLAVIVIRUS; HEMISPHERE; HISTOPATHOLOGY; NEUROPATHOLOGY; NEUROTROPISM; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; SPINAL CORD; VIRUS INFECTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES; ANTIGENS; CERCOPITHECUS AETHIOPS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; NEURONS; VERO CELLS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

LANGAT VIRUS; MACACA MULATTA; MUS; PRIMATES; TICK-BORNE ENCEPHALITIS VIRUS; YELLOW FEVER VIRUS (STRAIN 17D);

EID: 43949093800     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00172-08     Document Type: Article

References (48)

1. Angsubhakorn, S., J. B. Moe, J. R. Latendresse, G. S. Ward, M. Ngamprochana, S. Sahaphong, and N. Bhamarapravati. 1986. The neurovirulence of flaviviruses in crab-eating monkeys (Macaca fascicularis). Southeast Asian J. Trop. Med. Public Health 17:604-612.
2. Asher, D. M. 1975. Movement disorders in rhesus monkeys after infection with tick-borne encephalitis virus, vol. 10, p. 277-283. In B. S. Meldrum and C. D. Marsden (ed.), Advances in neurology. Raven Press, New York, NY.
3. Bodian, D., I. M. Morgan, and C. E. Schwerdt. 1950. Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice. Am. J. Hyg. 51:126-133.
4. Chambers, T. J., and M. S. Diamond. 2003. Pathogenesis of Flavivirus encephalitis. Adv. Virus Res. 60:273-342.
5. Durbin, A. P., R. A. Karron, W. Sun, D. W. Vaughn, M. J. Reynolds, J. R. Perreault, B. Thumar, R. Men, C. J. Lai, W. R. Elkins, R. M. Chanock, B. R. Murphy, and S. S. Whitehead. 2001. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in the 3′ untranslated region. Am. J. Trop. Med. Hyg. 65:405-413.
6. Frolova, M. P., and V. V. Pogodina. 1984. Persistence of tick-borne encephalitis virus in monkeys. VI. Pathomorphology of chronic infection in central nervous system. Acta Virol. 28:232-239.
7. Gelpi, E., M. Preusser, F. Garzuly, H. Holzmann, F. X. Heinz, and H. Budka. 2005. Visualization of Central European tick-borne encephalitis infection in fatal human cases. J. Neuropathol. Exp. Neurol. 64:506-512.
8. Gelpi, E., M. Preusser, U. Laggner, F. Garzuly, H. Holzmann, F. X. Heinz, and H. Budka. 2006. Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue. J. Neurovirol. 12:322-327.
9. Gritsun, T. S., V. A. Lashkevich, and E. A. Gould. 2003. Tick-borne encephalitis. Antiviral Res. 57:129-146.
10. Johnson, J. E., F. Nasar, J. W. Coleman, R. E. Price, A. Javadian, K. Draper, M. Lee, P. A. Reilly, D. K. Clarke, R. M. Hendry, and S. A. Udem. 2007. Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates. Virology 360:36-49.
11. Karganova, G. G., N. S. Pripuzova, N. V. Tereshkina, L. V. Gmyl', T. I. Dzhivanian, A. A. Rumyantsev, and V. A. Lashkevich. 2005. Residual neurovirulence of the chimera of Langat and Dengue-4 flaviviruses in intracerebral infection of monkeys. Vopr. Virusol. 50:27-31.
12. Komandenko, N. I., V. I. Il'enko, V. G. Platonov, and A. G. Panov. 1972. Clinical picture and pathogenesis of progressive forms of experimental tick-borne encephalitis. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova. 72:1000-1007.
13. Levenbook, I. S., L. J. Pelleu, and B. L. Elisberg. 1987. The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination. J. Biol. Stand. 15:305-313.
14. Maksimova, O. A., V. F. Popov, T. A. Bektimirov, L. V. Grigor'eva, T. N. Iunasova, O. P. Kaplunova, and O. K. Sharova. 2001. Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine. Vopr. Virusol. 46:31-35.
15. Malenko, G. V., G. I. Fokina, L. S. Levina, L. L. Mamonenko, O. E. Rzhakhova, V. V. Pogodina, and M. P. Frolova. 1982. Persistence of tick-borne encephalitis virus. IV. Virus localization after intracerebral inoculation. Acta Virol. 26:362-368.
16. Mandl, C. W., L. Iacono-Connors, G. Wallner, H. Holzmann, C. Kunz, and F. X. Heinz. 1991. Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev. Virology 185:891-895.
17. Marchevsky, R. S., M. S. Freire, E. S. Coutinho, and R. Galler. 2003. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology 316:55-63.
18. Martin, R. F., and D. M. Bowden. 2000. Primate brain maps: structure of the macaque brain. Elsevier, Amsterdam, The Netherlands.
19. Matveev, L. E., A. A. Godovikov, A. S. Karavanov, A. G. Pletnev, S. G. Rubin, I. V. Semashko, N. A. Tsekhanovskaya, M. P. Chumakov, and E. K. Pressman. 1989. The monoclonal antibodies against tick-borne encephalitis virus structural glycoprotein: preliminary characteristics. Vopr. Virusol. 34:694-697.
20. Maximova, O., E. Dragunsky, R. Taffs, P. Snoy, J. Cogan, S. Marsden, and I. Levenbook. 1996. Monkey neurovirulence test for live mumps vaccine. Biologicals 24:223-224.
21. Monath, T. P. 2005. Yellow fever vaccine. Expert Rev. Vaccines 4:553-574.
22. Monath, T. P., I. Levenbook, K. Soike, Z. X. Zhang, M. Ratterree, K. Draper, A. D. Barrett, R. Nichols, R. Weltzin, J. Arroyo, and F. Guirakhoo. 2000. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J. Virol. 74:1742-1751.
23. Monath, T. P., J. Arroyo, I. Levenbook, Z. X. Zhang, J. Catalan, K. Draper, and F. Guirakhoo. 2002. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J. Virol. 76:1932-1943.
24. Nathanson, N., A. M. Gittelsohn, I. S. Thind, and W. H. Price. 1967. Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses. Am. J. Epidemiol. 85:503-517.
25. Nathanson, N., and S. D. Horn. 1992. Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988. Vaccine 10:469-474.
26. Nathanson, N., D. Goldblatt, I. S. Thind, M. Davis, and W. H. Price. 1965. Histological studies of the monkey neurovirulence of group B arboviruses. 1. A semiquantitative grading scale. Am. J. Epidemiol. 82:359-381.
27. Nathanson, N., I. S. Thind, W. O'Leary, and W. H. Price. 1968. Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. Am. J. Epidemiol. 88:103-111.
28. Nathanson, N., M. Davis, I. S. Thind, and W. H. Price. 1966. Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am. J. Epidemiol. 84:524-540.
29. Pletnev, A. G., D. E. Swayne, J. Speicher, A. A. Rumyantsev, and B. R. Murphy. 2006. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 24:6392-6404.
30. Pletnev, A. G., M. Bray, J. Huggins, and C. J. Lai. 1992. Construction and characterization of tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. USA 89:10532-10536.
31. Pletnev, A. G. 2001. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3′ deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Virology 282:88-300.
32. Pletnev, A. G., M. Bray, and C. J. Lai. 1993. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J. Virol. 67:4956-4963.
33. Pletnev, A. G., M. Bray, K. A. Hanley, J. Speicher, and R. Elkins. 2001. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. J. Virol. 75:8259-8267.
34. Pletnev, A. G., V. F. Yamshchikov, and V. M. Blinov. 1990. Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus. Virology 174:250-263.
35. Pletnev, A. G., and R. Men. 1998. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc. Natl. Acad. Sci. USA 95:1746-1751.
36. Pletnev, A. G., R. Putnak, J. Speicher, E. J. Wagar, and D. W. Vaughn. 2002. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc. Natl. Acad. Sci. USA 99:3036-3041.
37. Pogodina, V. V., N. G. Bochkova, L. S. Karan', M. P. Frolova, A. G. Trukhina, G. V. Malenko, L. S. Levina, and A. E. Platonov. 2004. Comparative analysis of virulence of the Siberian and Far-East subtypes of the tick-borne encephalitis virus. Vopr. Virusol. 49:24-30.
38. Rozina, E. E., and M. Hilgenfeldt. 1985. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys. Acta Virol. 29:225-230.
39. Rumyantsev, A. A., R. M. Chanock, B. R. Murphy, and A. G. Pletnev. 2006. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine 24:133-143.
40. Sharova, O. K., E. E. Rozina, L. S. Shteinberg, N. M. Gordienko, and I. S. Kolyanova. 1979. Morphological characteristics of the pathological process in the central nervous system of monkeys infected with variants of measles virus strain L-16. Acta Virol. 23:393-397.
41. Smorodincev, A. A., and A. V. Dubov. 1986. Live vaccines against tick-borne encephalitis, p. 190-211. In A. A. Smorodincev (ed.), Tick-borne encephalitis and its vaccine prophylaxis. Meditsina, Leningrad, Russia.
42. Suss, J. 2003. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 21:S19-35.
43. Thind, I. S., and W. H. Price. 1966. A chick embryo attenuated strain (TP21 E5) of Langat virus. I. Virulence of the virus for mice and monkeys. Am. J. Epidemiol. 84:193-213.
44. Tsekhanovskaya, N. A., L. E. Matveev, S. G. Rubin, A. S. Karavanov, and E. K. Pressman. 1993. Epitope analysis of tick-borne encephalitis (TBE) complex viruses using monoclonal antibodies to envelope glycoprotein of TBE virus (persulcatus subtype). Virus Res. 30:1-16.
45. Whitehead, S. S., B. Falgout, K. A. Hanley, J. E. Blaney, L. Markoff, and B. R. Murphy. 2003. A live attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3′ untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77:1653-1657.
46. WHO. 1998. Requirements for yellow fever vaccine. WHO Tech. Rep. Ser. 872:38-40.
47. WHO. 2005. Final report. IABS scientific workshop on neurovirulence tests for live virus vaccines. WHO, Geneva, Switzerland, http://www.who.int/biologicals/publications/meetings/ Final%20Report%20WHO%20IABS %20Scientific%20Workshop%20on%20Neurovirulence%20Tests%20Jan_Feb%202005.pdf.
48. Wright, P. F., S. Ankrah, S. E. Henderson, A. P. Durbin, J. Speicher, S. S. Whitehead, B. R. Murphy, and A. G. Pletnev. 2008. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers. Vaccine 26:882-890.